Recombinant MS4A1 (Rituximab Biosimilar) 抗体
This Mammalian Cells 单克隆 anti-MS4A1 (Rituximab Biosimilar) antibody specifically detects MS4A1 (Rituximab Biosimilar) in ELISA. The antibody is reactive with 人 samples.
产品编号 ABIN7487776
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for Recombinant MS4A1 (Rituximab Biosimilar) 抗体 (ABIN7487776)
抗原
MS4A1 (Rituximab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Mammalian Cells
克隆类型
单克隆
标记
This MS4A1 (Rituximab Biosimilar) antibody is un-conjugated
应用范围
ELISA
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Rituximab Biosimilar - Anti-MS4A1 mAb
-
产品特性
- Antibody Type: IgG1
-
纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
-
亚型
- IgG1
-
-
anti-MS4A1 (Rituximab Biosimilar) antibody
适用: 人, Cynomolgus, 猕猴 FACS 宿主: 兔 Chimeric 10F381 unconjugated Recombinant Antibody
-
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS pH 7.5
-
储存条件
- 4 °C,-20 °C
-
储存方法
- 4°C for short term, -20°C for long term
-
-
- MS4A1 (Rituximab Biosimilar)
-
物质类
- Biosimilar
-
背景
-
Rituximab
Rituximab is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of immune system B cells. When it binds to this protein it triggers cell death. Rituximab is a medication used to treat certain autoimmune diseases and types of cancer. It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura, pemphigus vulgaris, myasthenia gravis and EpsteinBarr virus-positive mucocutaneous ulcers.
抗原
-
You are here:
